Catalyst Repository | Vor Biopharma Inc. Common Stock

Vor Biopharma Inc. Common Stock

(NASDAQ:VOR)

Description

Vor Biopharma, Inc., early-stage cell therapy company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

VOR Overview

None
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Previous Close
$3.3400
Previous Close Volume
191330